NORTH AMERICA BOTULINUM TOXIN MARKET FORECAST 2021-2028

The North America botulinum toxin market is predicted to grow with a CAGR of 4.77% across the forecast period, 2021 to 2028. The market growth of the region is attributed to factors such as the surging elderly populace and the presence of combination therapies for facial rejuvenation products.

north-america-botulinum-toxin-market

The North America botulinum toxin market growth assessment includes the analysis of the United States and Canada. Medical aesthetic technology has rapidly advanced in the United States over the last two decades, delivering a diverse range of solutions and products to patients seeking medical assistance. As per the American Society for Aesthetic Plastic Surgery, more than 1,712,900 procedures were performed with botulinum toxin in 2019. Moreover, botulinum toxin injection for treating facial wrinkles is considered the most frequently performed aesthetic procedure across the country.

The United States market is highly stringent in terms of aesthetic product regulation. In this regard, the Food and Drug Administration (FDA) approved absorbable dermal fillers for cheek augmentation and correcting skin folds, contour deficiency, and facial wrinkles, as well as non-absorbable dermal fillers for the correction of nasolabial folds and cheek acne scars for patients above the age of 21. In addition, the increased need for non-invasive aesthetic treatments and the rise in the country’s geriatric population further plays a vital role in fueling the market demand. As a result, the above-mentioned forces are set to fuel the botulinum toxin market growth in the United States during the forecast years.

US WorldMed LLC, headquartered in the United States, is a specialty pharmaceuticals company that licenses, develops, and markets unique healthcare products. Its product portfolio entails, Symjepi, Lucemyra, Revonto, Corgard, and Gelx Oral Gel. The company has pipeline candidates for introducing new therapies and indications across multiple therapeutic areas, such as Lofexidine, for opioid withdrawal.

TABLE OF CONTENTS
  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. SCOPE OF STUDY
    3. METHODOLOGY
    4. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. MARKET OVERVIEW
  3. MARKET DYNAMICS
    1. RELATED MARKET ANALYSIS: AESTHETIC FILLER MARKET
    2. KEY DRIVERS
      1. INCREASING DEMAND FOR AESTHETIC PROCEDURES
      2. EXPANSION OF BOTULINUM TOXIN INTO THERAPEUTIC APPLICATIONS
    3. KEY RESTRAINTS
      1. ADVERSE EFFECTS ASSOCIATED WITH BOTULINUM TOXIN
      2. LACK OF REIMBURSEMENT POLICIES SUPPORTING COSMETIC PROCEDURES
      3. LACK OF INTERCHANGEABILITY BETWEEN BOTULINUM TOXIN PRODUCTS
  4. KEY ANALYTICS
    1. IMPACT OF COVID-19 ON BOTULINUM TOXIN MARKET
    2. KEY MARKET TRENDS
    3. PORTER’S FIVE FORCES ANALYSIS
      1. BUYERS POWER
      2. SUPPLIERS POWER
      3. SUBSTITUTION
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    4. OPPORTUNITY MATRIX
    5. VENDOR LANDSCAPE
  5. MARKET BY TYPE
    1. TYPE A
    2. TYPE B
  6. MARKET BY APPLICATION
    1. COSMETIC APPLICATIONS
      1. GLABELLAR LINES
      2. LATERAL CANTHAL LINES (CROW’S FEET)
      3. FOREHEAD LINES
      4. OTHER COSMETIC APPLICATIONS
    2. NON-COSMETIC APPLICATIONS
      1. DYSTONIA
      2. CHRONIC MIGRAINE
      3. OPHTHALMOLOGIC DISORDERS
      4. OTHER NON-COSMETIC APPLICATIONS
  7. MARKET BY END-USER
    1. HOSPITALS
    2. CLINICS AND OTHERS
  8. GEOGRAPHICAL ANALYSIS
    1. NORTH AMERICA
      1. KEY GROWTH ENABLERS
      2. KEY CHALLENGES
      3. KEY PLAYERS
      4. COUNTRY ANALYSIS
        1. UNITED STATES       
        2. CANADA                     
  9. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. PRODUCT LAUNCHES & DEVELOPMENTS
    2. COMPANY PROFILES
      1. ABBVIE INC (ALLERGAN PLC)
      2. EVOLUS INC
      3. GALDERMA PHARMA SA (ACQUIRED BY EQT)
      4. HUGEL INC
      5. IPSEN PHARMA
      6. MEDYTOX INC
      7. MERZ PHARMA
      8. REVANCE THERAPEUTICS INC
      9. US WORLDMEDS LLC
LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - BOTULINUM TOXIN

TABLE 2: NORTH AMERICA BOTULINUM TOXIN MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 3: NORTH AMERICA BOTULINUM TOXIN MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 4: NORTH AMERICA BOTULINUM TOXIN MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 5: NORTH AMERICA BOTULINUM TOXIN MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 6: NORTH AMERICA BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 7: NORTH AMERICA BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 8: NORTH AMERICA BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 9: NORTH AMERICA BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 10: NORTH AMERICA BOTULINUM TOXIN MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 11: NORTH AMERICA BOTULINUM TOXIN MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 12:

TABLE 13: NORTH AMERICA BOTULINUM TOXIN MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 14: NORTH AMERICA BOTULINUM TOXIN MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

TABLE 15: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: NORTH AMERICA BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY TYPE, IN 2020

FIGURE 6: NORTH AMERICA BOTULINUM TOXIN MARKET, BY TYPE A, 2021-2028 (IN $ MILLION)

FIGURE 7: NORTH AMERICA BOTULINUM TOXIN MARKET, BY TYPE B, 2021-2028 (IN $ MILLION)

FIGURE 8: NORTH AMERICA BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2020

FIGURE 9: NORTH AMERICA BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 10: NORTH AMERICA BOTULINUM TOXIN MARKET, BY GLABELLAR LINES, 2021-2028 (IN $ MILLION)

FIGURE 11: NORTH AMERICA BOTULINUM TOXIN MARKET, BY LATERAL CANTHAL LINES (CROW’S FEET), 2021-2028 (IN $ MILLION)

FIGURE 12: NORTH AMERICA BOTULINUM TOXIN MARKET, BY FOREHEAD LINES, 2021-2028 (IN $ MILLION)

FIGURE 13: NORTH AMERICA BOTULINUM TOXIN MARKET, BY OTHER COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 14: NORTH AMERICA BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 15: NORTH AMERICA BOTULINUM TOXIN MARKET, BY DYSTONIA, 2021-2028 (IN $ MILLION)

FIGURE 16: NORTH AMERICA BOTULINUM TOXIN MARKET, BY CHRONIC MIGRAINE, 2021-2028 (IN $ MILLION)

FIGURE 17: NORTH AMERICA BOTULINUM TOXIN MARKET, BY OPHTHALMOLOGIC DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 18: NORTH AMERICA BOTULINUM TOXIN MARKET, BY OTHER NON-COSMETIC APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 19: NORTH AMERICA BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY END-USER, IN 2020

FIGURE 20: NORTH AMERICA BOTULINUM TOXIN MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)

FIGURE 21: NORTH AMERICA BOTULINUM TOXIN MARKET, BY CLINICS AND OTHERS, 2021-2028 (IN $ MILLION)

FIGURE 22: NORTH AMERICA BOTULINUM TOXIN MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 23: UNITED STATES BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)

FIGURE 24: CANADA BOTULINUM TOXIN MARKET, 2021-2028 (IN $ MILLION)

Request For A Free Sample